April 12, 2024
TOPLINE: No significant association was found between the use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and thyroid cancer over nearly 4 years. METHODOLOGY: A […]
April 12, 2024
TOPLINE: According to this meta-analysis, psoriatic arthritis (PsA) affects 112 out of every 100,000 adults globally, with higher rates observed in Europe and North America than […]
April 12, 2024
TOPLINE: Higher levels of body fat and visceral adipose tissue are associated with increased functional disability and reduced spinal mobility in patients with axial spondyloarthritis (axSpA) […]
April 12, 2024
TOPLINE: Patients with rheumatoid arthritis–associated interstitial lung disease (RA-ILD) have a high risk for serious and fatal infections, with age, inflammation, and corticosteroid therapy further increasing […]
April 12, 2024
TOPLINE: Subcutaneous tocilizumab provides durable disease control rates in patients with polyarticular and systemic juvenile idiopathic arthritis (pJIA and sJIA, respectively). METHODOLOGY: This long-term extension (LTE) […]
April 11, 2024
TOPLINE: Breaking up long sitting periods with short, frequent bouts of light-intensity walks may reduce the increased levels of postprandial vascular inflammatory biomarkers seen in people […]
April 11, 2024
TOPLINE: New estimates show that patient enrollment in cancer clinical trials focused on treatments is about twice as high now compared with past estimates, with rates […]
April 11, 2024
TOPLINE: Trimethylamine N-oxide (TMAO) is a gut microbiota-derived metabolite generated by metabolism of dietary L-carnitine, primarily from red meat, and choline, from a variety of animal […]
April 11, 2024
TOPLINE: Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be a better adjunct treatment to reduce anemia risk than glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for patients […]